Sanofi Extends Respiratory Vaccines Reach With $1.15B Acquisition of Clinical-Stage Vicebio
Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a ...
Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a ...
The world’s tech giants continue to go after strategic acquisitions aimed at deepening their presence in the healthcare world. On ...
Healthcare company Astrana Health has finalized the acquisition of Prospect Health, an integrated care delivery network, for $708 million, lower ...
Teleflex, a medical technology company, announced that it has finalized its acquisition of the vascular intervention business of Biotronik. In ...
AbbVie wasn’t part of the first wave of cell therapies developed for cancer, but it is positioning itself to contend ...
Capital Rx, a pharmacy benefit manager, has acquired care navigation company Amino Health, the companies announced on Wednesday. New York ...
AstraZeneca already has cell therapies in its pipeline, and it is now expanding its scope further with a deal to ...
Bluebird Bio, a company that steered three gene therapies to FDA approval but struggled to commercialize them, has found the ...
Avid Bioservices, a contract development manufacturing organization (CDMO) specializing in biologic drugs, is going private in an M&A deal that ...
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.